In 1978 the Pearson Commission in the United Kingdom rejected a no-fault system in dealing with clinical negligence. While declaring the existing tort system as costly, cumbersome, prone to delay, and too capricious in its operation to be defensible, the commission rejected no-fault compensation on grounds of the difficulty in overhauling the tort liability system and the perceived difficulties in causation judgments.1 A general conservatism in the legal profession and opposition from the insurance industry were other factors. Much has changed in the NHS since then.
The long overdue white paper on the reform of the clinical negligence compensation system is much awaited. Reforms to be considered include fixed tariffs for specific injuries, no-fault compensation, alternative dispute resolution, structured payouts instead of large one-off lump sums, and alternative non-cash methods of compensation such as home nursing care.2 The current system is based on the law of tort, which requires the claimant to prove harm caused by a breech of the duty of care. The adversarial and blame orientated nature of this system is not conducive to the culture of openness required by clinical governance and the NHS Plan. Supporters of the current system point to the threat of litigation as a deterrent to substandard care, although the evidence does not support this. Levels of medical litigation are five times as high in the United States than Canada, but no evidence exists that doctors in the United States deliver superior care. Any deterrent role is becoming increasingly redundant in the face of more effective risk management, clinical governance, peer review, and monitoring by hospital authorities and the General Medical Council.
In no-fault liability the claimant must show that the medical error was a causative factor in the resultant injury, irrespective of who is to blame (proof of causation rather than proof of fault). Medical accidents are an expected social phenomenon, and losses are calculated through an inquisitorial tribunal, which has access to all relevant documents and independent expert advice. The reduction in legal and administrative costs and a lower level of payouts offset the costs of greater numbers of claimants. The advantage is that claims can be investigated promptly, without the restriction of communication typical of the adversarial process.3 The system is deemed more equitable and efficient by the BMA and the royal colleges.
The royal colleges, cognisant that a no-fault system may seem to protect offending doctors, emphasise that negligent professionals would face disciplinary procedures.4 The colleges advocate a twin track system similar to that in Canada, where avoidable healthcare injuries are “designated compensable events” and subject to no-fault liability.
The BMA regards the present system as harmful, unpredictable, and unjust for both patients and medical staff. In the BMA model a no-fault compensation fund would handle compensation after causation is proved at a local level. The fund panel would work out compensation according to predetermined criteria. Smaller claims would be settled by individual trusts through the complaints procedure. Drug errors would be excluded as too complicated and expensive.5 A no-fault system in clinical negligence care would not be unique in the United Kingdom—similar systems exist in workmen's compensation schemes and police injury cases.
In reforming the system, lessons can be learned from experience in other countries. A Canadian task force recommended the introduction of limited no-fault compensation.6 Interestingly, many of the recommendations mirror the changes advocated by the NHS Plan and the Woolf reforms—such as contingency fees, case management, procedural measures to expedite the litigation process, methods of alternative dispute resolution, effective quality assurance, and risk management. In the United States capping malpractice awards and limiting contingency fees—lawyers often take a third of the compensation—have been introduced successfully in some states. Selective no-fault schemes are in place in Virginia and Florida, covering birth related neurological injury and vaccine injury. Another concept on trial in the United States is that of accelerated compensable events or designated compensable events. Certain defined medical injuries are compensated without proof of fault. The events tend to be avoidable and the system is being used in obstetrics.7 Some regard it as an incremental move towards a no-fault approach in the United States.
New Zealand is the greatest exponent of the no-fault system since it replaced the tort system in 1972 after the report of the Woodhouse Commission.8,9 Initial teething problems led to criticisms of compensation shortfalls, lack of accountability of doctors, and the definition of medical misadventure (used in place of medical negligence). In 1992 a reformed act was passed to address some of these criticisms and laid heavy emphasis on disciplining doctors at fault. The administrative costs are 10% of income, and the scheme seems to work well in the field of medical litigation.10 However, the minimal cover provided by the act and complete bar on the right to sue remain unique to New Zealand. The socialist legal ideology of Scandinavia also favours a no-fault principle in dealing with medical harm, relying on insurance rather than litigation. Sweden created an insurance system for patients in 1975, based on voluntary agreement, and Norway introduced a similar scheme in 1988. Denmark adopted a mandatory patients' insurance scheme similar to Finland.
In France medical negligence claims against the state are handled under an administrative law scheme, separate from the civil justice system and compensation for hospital mistakes is automatic.
In the United Kingdom a no-fault system would increase compliance with the mandatory reporting of adverse clinical events and would facilitate the culture of openness demanded by clinical governance, the NHS Plan, and the modern approach to look for errors in the organisations instead of blaming individuals.11,12 It should be introduced on a limited pilot basis and monitored closely for some years.
Footnotes
Competing interests: None declared.
References
- 1. Report of the Royal Commission on the Civil Liability and Compensation for Personal Injury. Chairman: Lord Pearson. Cmnd 7054-1, 1978 (paragraph 1715).
- 2.Department of Health. Clinical negligence—what are the issues and options for reform? London: Stationery Office; 2001. [Google Scholar]
- 3.Wadlington W. Medical injury compensation, a time for testing new approaches. JAMA. 1991;265:2861. [PubMed] [Google Scholar]
- 4.Jones M. Medical negligence. London: Sweet and Maxwell; 1995. [Google Scholar]
- 5.British Medical Association. Report of the working party on no fault compensation for medical injuries. London: BMA; 1991. [Google Scholar]
- 6.Pritchard JRS. Liability and compensation in health care: a report to the conference of deputy ministers of the Federal/Provincial/ Territorial review on liability and compensation issues in health care. 1990. [Google Scholar]
- 7.Sugarman SD. Doing away with tort law. Calif Law Rev. 1985;73:555. [Google Scholar]
- 8.Ison T. Accident compensation: a commentary on the New Zealand scheme. London: Croom Helm; 1980. [Google Scholar]
- 9.Oliphant K. Defining “medical misadventure:” lessons from New Zealand. Med Law Rev. 1996;4:1. [Google Scholar]
- 10.Giesen J. International medical malpractice law: a comparative law study of civil liability arising from medical care. 2nd ed. London: JCB Mohr; 1998. [Google Scholar]
- 11.Department of Health. Building a safer NHS for patients. London: Stationery Office; 2001. [Google Scholar]
- 12.Department of Health. London: Stationery Office; 2001. An organisation with a memory—report of an expert group on learning from adverse events in the NHS. [Google Scholar]